Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer

MLA

Zachary Tyerman, et al. “Utility of Circulating Tumor DNA for Predicting Prognosis in the Management of Resectable Pancreatic Cancer.” Journal of Cancer Metastasis and Treatment, vol. 8, Jan. 2022, p. 29. EBSCOhost, https://doi.org/10.20517/2394-4722.2022.20.

APA

Zachary Tyerman, Emily Ambler, Cary Jo R. Schlick, Felix Nwajei, & Akhil Chawla. (2022). Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer. Journal of Cancer Metastasis and Treatment, 8, 29. https://doi.org/10.20517/2394-4722.2022.20

Chicago

Zachary Tyerman, Emily Ambler, Cary Jo R. Schlick, Felix Nwajei, and Akhil Chawla. 2022. “Utility of Circulating Tumor DNA for Predicting Prognosis in the Management of Resectable Pancreatic Cancer.” Journal of Cancer Metastasis and Treatment 8 (January): 29. doi:10.20517/2394-4722.2022.20.